The resilience of Canopy Growth (TSX: WEED) faces renewed scrutiny as its streak of financial losses persists into the first quarter, raising concerns about its long-term viability.
Canopy’s quarterly net revenue displayed modest growth, climbing by 3% to $108.7 million from last year’s $105.9 million, a boost attributed to the expansion of its BioSteel division specializing in sports nutrition products.
As of June 30, the Ontario-based enterprise held $533.3 million in cash and cash equivalents, a decrease from the $677 million reported at the close of March. During the reported quarter, the company’s total debt amounted to $1.05 billion.
Nonetheless, the forthcoming second-quarter sales are anticipated to dip in sequential comparison due to seasonal factors, as outlined by Chief Financial Officer Judy Hong during a post-earnings conference call.
“Our performance in the first quarter of Fiscal 2024 validates the difficult but transformative changes we made over the last twelve months,” said CEO David Klein.
Compared to last year, this quarter yielded a profitable gross margin, coming in at $5.9 million versus a gross loss of $5.6 million in the previous period. Net loss for the quarter also improved to $41.9 million compared to last year’s one-time huge $2.09 billion net loss due to asset impairments and restructuring.
Complicating matters, an investigation by the U.S. Securities and Exchange Commission looms over the company regarding the disclosure of BioSteel’s revenue figures.
Prompted by this challenge, Canopy initiated an internal review of its BioSteel division in June, resulting in the overhaul of key leadership positions following the assessment’s conclusion.
For the three-month period ending June 30, the company managed to narrow its adjusted EBITDA loss to $57.8 million, a reduction from the $79 million loss recorded in the same period a year prior, thanks in part to effective cost-cutting measures.
Notably, cost reductions of $47 million were achieved during the quarter, even as the company encountered elevated warehousing and production expenses linked to the BioSteel manufacturing facility situated in Verona, Virginia.
In its pursuit of profitability, the company has undertaken a series of strategic measures, including workforce reductions, withdrawal from select global markets, shuttering of retail outlets, and divestment of its Canadian retail operations.
Canopy Growth last traded at $0.61 on the TSX.
Information for this briefing was found via Sedar, Reuters, and the sources mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
